252 related articles for article (PubMed ID: 26853560)
1. Tumor suppressor properties of the splicing regulatory factor RBM10.
Hernández J; Bechara E; Schlesinger D; Delgado J; Serrano L; Valcárcel J
RNA Biol; 2016; 13(4):466-72. PubMed ID: 26853560
[TBL] [Abstract][Full Text] [Related]
2. An RRM-ZnF RNA recognition module targets RBM10 to exonic sequences to promote exon exclusion.
Collins KM; Kainov YA; Christodolou E; Ray D; Morris Q; Hughes T; Taylor IA; Makeyev EV; Ramos A
Nucleic Acids Res; 2017 Jun; 45(11):6761-6774. PubMed ID: 28379442
[TBL] [Abstract][Full Text] [Related]
3. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
4. miR-335 modulates Numb alternative splicing via targeting RBM10 in endometrial cancer.
Dou XQ; Chen XJ; Zhou Q; Wen MX; Zhang SZ; Zhang SQ
Kaohsiung J Med Sci; 2020 Mar; 36(3):171-177. PubMed ID: 31894898
[TBL] [Abstract][Full Text] [Related]
5. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.
Bechara EG; Sebestyén E; Bernardis I; Eyras E; Valcárcel J
Mol Cell; 2013 Dec; 52(5):720-33. PubMed ID: 24332178
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis reveals that RBM10 mutations contribute to lung adenocarcinoma pathogenesis by deregulating splicing.
Zhao J; Sun Y; Huang Y; Song F; Huang Z; Bao Y; Zuo J; Saffen D; Shao Z; Liu W; Wang Y
Sci Rep; 2017 Jan; 7():40488. PubMed ID: 28091594
[TBL] [Abstract][Full Text] [Related]
7. RNA binding motif protein 10 suppresses lung cancer progression by controlling alternative splicing of eukaryotic translation initiation factor 4H.
Zhang S; Bao Y; Shen X; Pan Y; Sun Y; Xiao M; Chen K; Wei H; Zuo J; Saffen D; Zong WX; Sun Y; Wang Z; Wang Y
EBioMedicine; 2020 Nov; 61():103067. PubMed ID: 33130397
[TBL] [Abstract][Full Text] [Related]
8. RBM10 regulates alternative splicing.
Inoue A; Yamamoto N; Kimura M; Nishio K; Yamane H; Nakajima K
FEBS Lett; 2014 Mar; 588(6):942-7. PubMed ID: 24530524
[TBL] [Abstract][Full Text] [Related]
9. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.
Sun Y; Bao Y; Han W; Song F; Shen X; Zhao J; Zuo J; Saffen D; Chen W; Wang Z; You X; Wang Y
Nucleic Acids Res; 2017 Aug; 45(14):8524-8540. PubMed ID: 28586478
[TBL] [Abstract][Full Text] [Related]
10. RBM10 Regulates Tumor Apoptosis, Proliferation, and Metastasis.
Cao Y; Di X; Zhang Q; Li R; Wang K
Front Oncol; 2021; 11():603932. PubMed ID: 33718153
[TBL] [Abstract][Full Text] [Related]
11. RBM10, a New Regulator of p53.
Jung JH; Lee H; Zeng SX; Lu H
Cells; 2020 Sep; 9(9):. PubMed ID: 32947864
[TBL] [Abstract][Full Text] [Related]
12. Dengue virus targets RBM10 deregulating host cell splicing and innate immune response.
Pozzi B; Bragado L; Mammi P; Torti MF; Gaioli N; Gebhard LG; García Solá ME; Vaz-Drago R; Iglesias NG; García CC; Gamarnik AV; Srebrow A
Nucleic Acids Res; 2020 Jul; 48(12):6824-6838. PubMed ID: 32432721
[TBL] [Abstract][Full Text] [Related]
13. Splicing Site Recognition by Synergy of Three Domains in Splicing Factor RBM10.
Serrano P; Hammond JA; Geralt M; Wüthrich K
Biochemistry; 2018 Mar; 57(10):1563-1567. PubMed ID: 29450990
[TBL] [Abstract][Full Text] [Related]
14. The RNA-binding landscape of RBM10 and its role in alternative splicing regulation in models of mouse early development.
Rodor J; FitzPatrick DR; Eyras E; Cáceres JF
RNA Biol; 2017 Jan; 14(1):45-57. PubMed ID: 27763814
[TBL] [Abstract][Full Text] [Related]
15. Functional insight into a neurodevelopmental disorder caused by missense variants in an RNA-binding protein, RBM10.
Imagawa E; Moreta L; Misra VK; Newman C; Konuma T; Oishi K
J Hum Genet; 2023 Sep; 68(9):643-648. PubMed ID: 37268768
[TBL] [Abstract][Full Text] [Related]
16. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation.
Wang Y; Gogol-Döring A; Hu H; Fröhler S; Ma Y; Jens M; Maaskola J; Murakawa Y; Quedenau C; Landthaler M; Kalscheuer V; Wieczorek D; Wang Y; Hu Y; Chen W
EMBO Mol Med; 2013 Sep; 5(9):1431-42. PubMed ID: 24000153
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding motif protein 10 induces apoptosis and suppresses proliferation by activating p53.
Jung JH; Lee H; Cao B; Liao P; Zeng SX; Lu H
Oncogene; 2020 Jan; 39(5):1031-1040. PubMed ID: 31591476
[TBL] [Abstract][Full Text] [Related]
18. RBM10 C761Y mutation induced oncogenic ASPM isoforms and regulated β-catenin signaling in cholangiocarcinoma.
Chang J; Zhang Y; Zhou T; Qiao Q; Shan J; Chen Y; Jiang W; Wang Y; Liu S; Wang Y; Yu Y; Li C; Li X
J Exp Clin Cancer Res; 2024 Apr; 43(1):104. PubMed ID: 38576051
[TBL] [Abstract][Full Text] [Related]
19. Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levels.
Ozuemba B; Masilamani TJ; Loiselle JJ; Koenderink B; Vanderbeck KA; Knee J; Larivière C; Sutherland LC
Gene; 2016 Apr; 580(1):26-36. PubMed ID: 26784654
[TBL] [Abstract][Full Text] [Related]
20. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b.
Atsumi T; Suzuki H; Jiang JJ; Okuyama Y; Nakagawa I; Ota M; Tanaka Y; Ohki T; Katsunuma K; Nakajima K; Hasegawa Y; Ohara O; Ogura H; Arima Y; Kamimura D; Murakami M
Int Immunol; 2017 Dec; 29(12):581-591. PubMed ID: 29309623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
